DGX Filing
4Filing Date: Jul 27, 2026
QUEST DIAGNOSTICS INC (DGX) · Insider Trading (Form 4) SEC Filing
Statement of Changes in Beneficial Ownership
descriptionView SEC Filing
ACC: 0001022079-26-000080open_in_new
Total Value$1.2K
Trades1
Insiders1
Transaction Details
Lassiter Wright III
Director·Direct
· Acquire
Common Stock
Shares+6
Price$206.81
Total Value$1.2K
Shares Owned After10.32K
Transaction DateJul 22, 2026
Footnotes ▸
Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.
Post-Transaction Holdings
Lassiter Wright III
| Security | Shares | Change |
|---|---|---|
| Common Stock | 10.32K | +6 (0.06%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-07-22
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: QUEST DIAGNOSTICS INC (DGX)
CIK: 0001022079
--- Reporting Owner ---
Name: Lassiter Wright III
CIK: 0001805909
Role: Director
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-07-22 | Code: L
Shares: +6 | Price: $206.81
Total Value: $1,240.88
Shares Owned After: 10,323 | Ownership: D (Direct)
Footnotes:
[F1] Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.
--- Footnotes (Complete Index) ---
F1: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.
--- Signature ---
/s/ Sean D. Mersten, Attorney in Fact for Wright L. Lassiter, III (2026-07-27)